Related Experiment Video
Updated: Jan 28, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Nanoparticle Therapy for Vascular Diseases
Alyssa M Flores1,2, Jianqin Ye1, Kai-Uwe Jarr1
1From the Division of Vascular Surgery, Department of Surgery (A.M.F., J.Y., K.-U.J., N.J.L.), Stanford University School of Medicine, CA.
Abstract:
Nanoparticles promise to advance strategies to treat vascular disease. Since being harnessed by the cancer field to deliver safer and more effective chemotherapeutics, nanoparticles have been translated into applications for cardiovascular disease. Systemic exposure and drug-drug interactions remain a concern for nearly all cardiovascular therapies, including statins, antithrombotic, and thrombolytic agents. Moreover, off-target effects and poor bioavailability have limited the development of completely new approaches to treat vascular disease. Through the rational design of nanoparticles, nano-based delivery systems enable more efficient delivery of a drug to its therapeutic target or even directly to the diseased site, overcoming biological barriers and enhancing a drug's therapeutic index. In addition, advances in molecular imaging have led to the development of theranostic nanoparticles that may simultaneously act as carriers of both therapeutic and imaging payloads. The following is a summary of nanoparticle therapy for atherosclerosis, thrombosis, and restenosis and an overview of recent major advances in the targeted treatment of vascular disease.
Insights
Nanoparticles offer advanced treatments for vascular diseases like atherosclerosis and thrombosis. These nano-based delivery systems improve drug targeting and bioavailability, enhancing therapeutic outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cardiovascular Medicine
Background:
- Cardiovascular therapies face challenges including systemic exposure, drug-drug interactions, off-target effects, and poor bioavailability.
- Nanoparticles, initially successful in cancer chemotherapy, are now being explored for cardiovascular disease treatment.
- Existing treatments for atherosclerosis, thrombosis, and restenosis have limitations that hinder efficacy and safety.
Purpose of the Study:
- To summarize nanoparticle therapy applications for vascular diseases such as atherosclerosis, thrombosis, and restenosis.
- To provide an overview of recent advancements in targeted nanoparticle-based treatments for cardiovascular conditions.
- To highlight how rational nanoparticle design overcomes biological barriers for enhanced drug delivery.
Main Methods:
- Review of current literature on nanoparticle applications in cardiovascular disease.
- Analysis of nanoparticle design principles for targeted drug delivery.
- Exploration of theranostic nanoparticle development for simultaneous therapy and imaging.
Main Results:
- Nanoparticles enable more efficient drug delivery to diseased sites, overcoming biological barriers.
- Rational design of nanoparticles enhances drug bioavailability and therapeutic index.
- Theranostic nanoparticles offer combined therapeutic and diagnostic capabilities.
Conclusions:
- Nanoparticle-based strategies show significant promise for advancing the treatment of vascular diseases.
- Targeted delivery systems are crucial for improving the efficacy and safety of cardiovascular therapies.
- Future research in nanomedicine holds potential for novel treatments for atherosclerosis, thrombosis, and restenosis.
Related Concept Videos
Gene Therapy
Seedless Vascular Plants
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Group Therapy
Vascular Spasm
Overview of the Vascular System

